3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Esophageal Neoplasms
2
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Adenocarcinoma Of Esophagus
1
Interventions
Rituximab
8
Magnetic Resonance Spectroscopy
6
venetoclax
5
Cyclophosphamide
5
Specimen Handling
4
Lenalidomide
4
obinutuzumab
3
Whole-Body Irradiation
3
Prednisone
3
Cyclosporine
3
CT-P10
3
Biopsy
3
zanubrutinib
2
pirtobrutinib
2
ibrutinib
2
fludarabine phosphate
2
fludarabine
2
Vincristine
2
Mycophenolic Acid
2
Doxorubicin
2
treosulfan
1
prednylidene
1
pomalidomide
1
polatuzumab vedotin
1
orelabrutinib
1
deltacortene
1
copanlisib
1
cc-486
1
Tacrolimus
1
Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
trastuzumab biosimilar HLX02
×
30 days
×
Clear all
No trials found.